Why Small Pharma Firms Prefer Third Party Manufacturing

It takes a lot of work to bring a new medication to the market. New small pharmaceutical and startup companies have to find a way to raise funds to deal with the many complex and peculiar challenges of the pharmaceutical industry. Something that many of these companies have to deal with is construction and manufacturing. Construction and manufacturing of a plant is a great deal of work. This is why many small construction and manufacturing companies have began looking for an alternative approach. They have begun looking for contract manufacturing firms and companies.

By partnering with a specialized contract manufacturing organization (CMO), smaller firms can bypass the heavy investment of in-house production. This is important because it allows companies to redirect and to concentrate the value of the research and plant that they have. In the rest of this post, I will describe the benefits of this type of business and, explain how it, helps businesses to grow, to compete, and to keep their standards in a market that is is moving very fast and very vigorously.

What is Third-Party Pharma Manufacturing?

Third-party pharma manufacturing refers to a business model whereby a pharmaceutical company subcontracts the production of some or all of its products to a manufacturing partner. This manufacturing partner is often referred to as a Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO). They provide certain production services, which may include obtaining the raw materials, formulating the products, the actual production and packing of the products, and even the quality control—all tailored to the specifications of the contracting company.   

This model is particularly useful to pharma companies that wish to launch their products without the overhead costs associated with the acquisition and operation of a manufacturing plant. In such cases, the pharma company simply enters into a strategic partnership and relies on the CMO's manufacturing capabilities.   

The Core Benefits of Third-Party Manufacturing for Small Firms

Most pharma startups who wish to become franchise pharma companies or small niche pharma companies for certain niche treatments will find value in this model. The advantages of this model in addressing the challenges usually encountered by smaller firms in the primarily unregulated niche pharmaceutical market are numerous.

1. Significant Cost Savings and Capital Efficiency

Financial benefits are perhaps the biggest advantages in the leasing of GMP (Good Manufacturing Practice) facilities. The construction of GMP facilities requires millions of dollars which then also need to be operationalized. This includes the ongoing costs for staff maintenance, utilities, and compliance.

Small firms outsourcing GMP facilities leasing. This results in the conversion of predicted capital expenditure into predictable operational expenditure. This in turn results in the reclamation of valuable capital that can be realigned to core business functions like research and development, clinical trials, and marketing. Companies can avoid heavy investments in facilities and remain flexible and thin financially.

2. Access to Specialized Expertise and Advanced Technology

Expert manufacturing facility contracted CMOs and law firms provide complete manufacturing outsourcing and set-up construction. They possess and develop proprietary processes for optimization, automation of workflow, and capture of compliance and quality processes. CMO's regulatory compliance driven operational manufacturing workflow also includes advanced equipment class for compliance to cGMP.

An example of a CMO facility leasing partnership in the dermatology space for a small PCD pharma company is CMO's advanced dermatological cream, ointment, and lotion formulation and filling machines. The first CMO partnership allows the small company to access dermatological formulation and filling technology developed over years of expensive and capital intense in-house development. This is a common strategy for companies offering a derma PCD pharma franchise.

3. Faster Time-to-Market

In the pharmaceutical business, the ability to move quickly gives a company the ability to make more profit. Every day a company waits to launch a product is a day they could be earning profit. Constructing and certifying a new manufacturing building could take years. On the other hand, working with a contracted manufacturer will help reduce the time needed to get to market.

Contracted manufacturers, or CMOs, are capable of quickly increasing production when the new formula is approved. This is critical for small pharmaceutical companies, who need to sell their products quickly to make revenue. This ability to quickly get products to market is critical for addressing competition. Large pharmaceutical companies have more resources, so they are more difficult to compete against.

4. Scalability and Production Flexibility

A new, small firm, may underestimate the demand for a new drug and decide to start with low production, but what will they do if they rapidly sell out and demand surges? The scale of in-house manufacturing will be a bottleneck and will require significant cash in order to expand, while excess scale will result in expensive equipment sitting idle which is a poor investment.

CMOs provide remarkable adaptability. They can customize their production schedules, either increasing or decreasing output, based on their client's needs. This helps smaller companies deal with the market's risks without having overly fixed production systems. CMOs, for example, can help with everything from new products for ayurvedic PCD pharma franchises to other specialized dermatological treatments.

How Does Third-Party Manufacturing Help Pharma Companies in India Scale?

India has become one of the leading centres of pharmaceutical manufacturing and has become the ‘pharmacy of the world.’ The range of offerings includes large and diversified players, and a larger and growing number of smaller and new firms and start-ups. For the Indian pharma industry, growth and competitiveness hinges on third party manufacturing.

Many of the top most pharma companies in India began by leveraging contract manufacturing to build their portfolios before investing in their own large-scale facilities. This strategy is even more critical today for emerging companies. By outsourcing, they can:

• Launch a Diverse Product Portfolio: A new or small company can work with multiple Contract Manufacturing Organisations (CMOs) who specialize in making different types of medicines (like pills, injections and syrups) and develop a wide range of offerings pharmaceutical without a huge upfront capital. This is essential for those building a derma company franchise or other specialized franchise models.
   
• Focus on a PCD Franchise Model: The PCD (Propaganda-Cum-Distribution) model is extremely common in our country. An entrepreneur with a derma PCD franchise or an ayurvedic PCD pharma franchise can concentrate mainly on promotional activities and distribution, and let a trusted firm handle production. This model allows the franchisor to have manufacturing and distribution assets.
   
• Meet Global Quality Standards: Reputable Indian CMOs adhere to international quality standards, including WHO-GMP, ISO, and others. This enables smaller Indian firms to produce goods suitable for both domestic and export markets, expanding their reach. The goal is to be recognized as India's best medicine company, and quality is non-negotiable.

Overcoming the Challenge of a Monopoly Pharma Company

The pharmaceutical industry often has segments dominated by a monopoly pharma company or a few large corporations. Having large distribution networks and monopolistic marketing distribution absolutely chains a small company's or firm's competitive ability

Third-party manufacturing is a great equalizer. It lowers the barrier to entry, allowing innovative startups to bring their products to market without needing to match the capital expenditure of industry titans. By focusing resources on R&D to create a superior product and on targeted marketing strategies, small firms can carve out a niche. Outsourcing production levels the playing field, enabling them to compete on the merits of their science and business strategy, not just the size of their factory.

Finding the Right Manufacturing Partner

Choosing a CMO is a critical decision that will impact your company's future. It's not just about cost; it's about finding a true partner. Key factors to consider include:

• Regulatory Compliance and Quality Record: Ensure the CMO has a strong track record with regulatory bodies like the FDA, EMA, and WHO.
• Technical Capabilities: Does the manufacturer have the specific equipment and expertise required for your product?
• Scalability: Can they handle your projected volumes, both now and in the future?
• Communication and Transparency: A good partner is open, collaborative, and communicative throughout the process.
• Financial Stability: Verify that your chosen partner is financially healthy to avoid disruptions.

Your Partner for Pharmaceutical Growth

Outsourcing manufacturing allows small pharma companies to become more flexible, cheaper, and more competitive. It also enables them to concentrate on their primary competencies. Innovation, research, and market development are accelerated when a company partners with a dedicated manufacturer that has expertise and established framework. The success of expanding an ayurvedic product range and launching a specialized dermatology product line is proof of this.

Are you ready to accelerate your journey from R&D to market? Partnering with an experienced third-party manufacturer can unlock your company's full potential.

Ready to scale your pharmaceutical business without the burden of in-house manufacturing? Contact our team today to learn how our state-of-the-art facilities and expert team can help you bring your products to market faster and more efficiently.